Unknown

Dataset Information

0

Topical Tranexamic Acid Reduces Blood Loss in Minimally Invasive Total Knee Arthroplasty Receiving Rivaroxaban.


ABSTRACT: It is unclear whether topical (intra-articular) or intravenous TXA reduces blood loss in minimally invasive TKA patients receiving a direct oral anticoagulant for thromboprophylaxis. This study is to investigate whether TXA given intravenously or intra-articularly is effective in reducing blood loss in minimally invasive TKA patients using rivaroxaban for thromboprophylaxis.Ninety-three patients who underwent primary minimally invasive TKA were divided into placebo group (30 patients) that received saline both intravenously and intra-articularly, intravenous (IV) group (31 patients) that received 1?g TXA intravenously, and topical group (32 patients) that received 3?g TXA in 100?ml saline intra-articularly. All patients received oral rivaroxaban of 10?mg daily for 14 days postoperatively.p < 0.001 and p = 0.041. The mean total blood loss was 1131?mL (567-1845) in placebo, which was higher than that in the IV group (921?mL; range, 465-1495; p = 0.014) and the topical group (795?mL; range, 336-1350; p < 0.001). The total blood loss did not differ between the IV and the topical group (p = 0.179).This prospective, randomized, controlled trial demonstrated an equal efficacy of TXA in blood conservation when administered intravenously or topically in minimally invasive TKA patients receiving rivaroxaban for thromboprophylaxis.

SUBMITTER: Yen SH 

PROVIDER: S-EPMC5749315 | biostudies-literature | 2017

REPOSITORIES: biostudies-literature

altmetric image

Publications

Topical Tranexamic Acid Reduces Blood Loss in Minimally Invasive Total Knee Arthroplasty Receiving Rivaroxaban.

Yen Shih-Hsiang SH   Lin Po-Chun PC   Chen Bradley B   Huang Chung-Chen CC   Wang Jun-Wen JW  

BioMed research international 20171219


<h4>Background</h4>It is unclear whether topical (intra-articular) or intravenous TXA reduces blood loss in minimally invasive TKA patients receiving a direct oral anticoagulant for thromboprophylaxis. This study is to investigate whether TXA given intravenously or intra-articularly is effective in reducing blood loss in minimally invasive TKA patients using rivaroxaban for thromboprophylaxis.<h4>Methods</h4>Ninety-three patients who underwent primary minimally invasive TKA were divided into pla  ...[more]

Similar Datasets

| S-EPMC3807723 | biostudies-literature
| S-EPMC4162390 | biostudies-literature
| S-EPMC2504119 | biostudies-other
| S-EPMC5643894 | biostudies-literature
| S-EPMC7303488 | biostudies-literature
| S-EPMC7822658 | biostudies-literature
| S-EPMC6583493 | biostudies-literature
| S-EPMC7749894 | biostudies-literature
| S-EPMC5859255 | biostudies-literature
| S-EPMC6148574 | biostudies-literature